Gagnon Securities LLC Maxcyte, Inc. Transaction History
Gagnon Securities LLC
- $474 Million
- Q3 2024
A detailed history of Gagnon Securities LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Gagnon Securities LLC holds 59,069 shares of MXCT stock, worth $203,788. This represents 0.05% of its overall portfolio holdings.
Number of Shares
59,069
Previous 56,506
4.54%
Holding current value
$203,788
Previous $221,000
3.62%
% of portfolio
0.05%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$28.3 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$28.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$19.9 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$17.4 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$16.6 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $351M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...